Androgenetic Alopecia (AGA)

DBCOND0064452Endocrine System DiseasesSigns, Symptoms, and General Pathologies

Androgenetic Alopecia (AGA) is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Androgenetic Alopecia · Male Pattern Baldness · Alopecia, Androgenetic · Alopecia Androgenica · Androgenic Alopecia
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0000759ICD-10L64SNOMED CT201144006MedDRA10025514UMLSC0162311

What you can answer from here — as of November 03, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
157Clinical trialsPhase, status and sponsor resolved per trial
Sign in
8Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Androgenetic Alopecia (AGA) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In